dipyridamole has been researched along with phenyl acetate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Armbrecht, JJ; Buxton, DB; Schelbert, HR | 1 |
| Blaise, G; Boulanger, Y; Cardoso, M; Gougoux, A; Léveillé, M; Noël, J; Prud'homme, M; Vinay, P; Vinet, B | 1 |
| Askari, A; Rao, SN | 1 |
| Gautieri, RF; Ward, CO | 1 |
| Kambara, H; Konishi, J; Mohiuddin, IH; Nohara, R; Okuda, K; Ono, S; Tamaki, N | 1 |
| Buxton, DB; Chen, K; Choi, Y; Hansen, HW; Huang, SC; Kim, AS; Müller, P; Phelps, ME; Schelbert, HR; Siegel, S; Sun, KT | 1 |
| Chen, S; Fang, Q; Li, Y; Ma, F; Zhu, J | 1 |
| Dave, RH; Matharu, AS; Motto, MG; Patel, MR; Simonelli, AP | 1 |
| Abdelkawy, M; El-Ragehy, NA; Hassan, NY; Tantawy, MA | 1 |
| Ma, C; Wang, J | 1 |
| Huang, YY; Li, Z; Lin, Y; Liu, R; Luo, HB; Wang, X; Zhan, CG | 1 |
12 other study(ies) available for dipyridamole and phenyl acetate
| Article | Year |
|---|---|
Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium.
Topics: Acetates; Animals; Carbon Dioxide; Carbon Radioisotopes; Coronary Circulation; Dipyridamole; Dogs; Hyperemia; Ischemia; Kinetics; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Tomography, Emission-Computed | 1990 |
Metabolic effects of acetate on the heart.
Topics: Acetates; Acetic Acid; Adenosine; Adenosine Triphosphate; Animals; Chromatography, High Pressure Liquid; Coronary Circulation; Dipyridamole; Glucose; Heart; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Myocardium; Phosphates; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains; Theophylline; Vasodilation | 1989 |
Drugs affecting sodium transport in human erythrocyte ghosts.
Topics: Acetates; Adenosine Triphosphatases; Anesthetics, Local; Biological Transport, Active; Cell Membrane; Chlorpromazine; Desipramine; Dipyridamole; Erythrocytes; Ethacrynic Acid; Furosemide; Humans; Imipramine; Iodine; Lactates; Oligomycins; Ouabain; Potassium; Pyruvates; Sodium | 1970 |
Effect of certain drugs on perfused human placenta. 8. Angiotensin-II antagonists.
Topics: Acetates; Angiotensin II; Atropine; Blood Pressure Determination; Cobalt; Cocaine; Cyproheptadine; Dibenzylchlorethamine; Dipyridamole; Ethanol; Female; Furans; Glycols; Humans; Hydralazine; In Vitro Techniques; Isosorbide Dinitrate; Muscles; Nitrates; Nitrites; Nitroglycerin; Papaverine; Perfusion; Phentolamine; Placenta; Pregnancy; Sodium; Sympatholytics; Tartrates; Tolazoline | 1968 |
[Assessment of myocardial metabolic reserve with positron emission tomography and C-11 acetate].
Topics: Acetates; Adult; Aged; Blood Pressure; Carbon Radioisotopes; Dipyridamole; Dobutamine; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardium; Tomography, Emission-Computed | 1993 |
Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate.
Topics: Acetates; Animals; Body Fluid Compartments; Carbon Dioxide; Carbon Radioisotopes; Chi-Square Distribution; Computer Simulation; Coronary Circulation; Dipyridamole; Dobutamine; Dogs; Fatty Acids, Nonesterified; Models, Cardiovascular; Myocardium; Oxygen Consumption; Tomography, Emission-Computed; Xylazine | 1997 |
[New antiplatelet agents].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Tirofiban; Tyrosine | 2000 |
Preparation and characterization of solid dispersions of dipyridamole with a carrier "copolyvidonum Plasdone S-630".
Topics: Acetates; Calorimetry, Differential Scanning; Dipyridamole; Drug Carriers; Microscopy, Polarization; Platelet Aggregation Inhibitors; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2007 |
Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
Topics: Acetates; Algorithms; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diffusion; Dipyridamole; Drug Delivery Systems; Excipients; Gastrointestinal Transit; Hydrogen-Ion Concentration; Hypromellose Derivatives; Kinetics; Methylcellulose; Models, Chemical; Povidone; Solubility; Tablets; Water | 2011 |
Simultaneous Determination of Aspirin, Dipyridamole and Two of Their Related Impurities in Capsules by Validated TLC-Densitometric and HPLC Methods.
Topics: Acetates; Aspirin; Capsules; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Densitometry; Dipyridamole; Hydrogen-Ion Concentration; Methanol; Reproducibility of Results; Salicylic Acid; Solvents; Tartrates; Toluene | 2016 |
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles | 2021 |
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles | 2021 |